Plasma levels of asymmetric dimethylarginine (ADMA), an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell disease. [electronic resource]
Producer: 20050811Description: 282-6 p. digitalISSN:- 0939-5555
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.